Author

Mojtaba Tabandeh

Wenzhou-Kean UniversityORCID 0000-0002-2158-2631Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Approach:simulation· 1 Approach:statistical model· 1

Frequent Co-Authors

Chengxu Xie· 3 shared Lifang ZhangiD· 3 shared Vishwa DeepakiD· 3 shared Xinyi Bao· 3 shared Farwa Basit· 2 shared Heriberto VélëziD· 2 shared Xiaohan Li· 2 shared Yili DingiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Chengxu Xie

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologyInternational Journal of Molecular SciencesPeer-reviewedAug 11, 2026

Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK-c-Fos-NFATc1 Axis

Lifang Zhang, Chengxu Xie, Xinyi Bao…·Vishwa Deepak

This study shows asarinin inhibits osteoclast differentiation by blocking the p38/ERK-c-Fos-NFATc1 pathway in RANKL-stimulated cells.

DOI 10.3390/ijms27167159

experimental assayhost-pathogen & immune response

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintAug 4, 2026

IKKβ as a putative non-covalent and quinone-mediated covalent target of 4-methylcatechol in RANKL/NF-κB signaling: a combined computational and experimental analysis

Chengxu Xie, Lifang Zhang, Xinyi Bao…·Vishwa Deepak

This study investigates how 4-methylcatechol affects RANKL-induced osteoclastogenesis by targeting IKKβ through non-covalent and covalent mechanisms.

DOI 10.64898/2026.07.29.741661

humanstatistical model

𝕏 PostBluesky

Pharmacology & ToxicologyFrontiers in PharmacologyPeer-reviewedJun 3, 2026

Methyl Carnosate, a Carnosic Acid Derivative, Attenuates Osteoclastogenesis via Modulation of RANKL-Induced NF-κB Activity

Lifang Zhang, Chengxu Xie, Xinyi Bao…·Vishwa Deepak

The paper identifies methyl carnosate as a potent inhibitor of RANKL-induced osteoclastogenesis with an IC50 of 1.2 M, showing greater efficacy than carnosic acid.

1 citation

experimental assayhost-pathogen & immune response

𝕏 PostBluesky